Compare CDRE & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDRE | PAHC |
|---|---|---|
| Founded | 2012 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2021 | 2014 |
| Metric | CDRE | PAHC |
|---|---|---|
| Price | $27.43 | $35.18 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $39.67 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 285.9K | 222.1K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.46% | 0.91% |
| EPS Growth | 13.33 | ★ 104.20 |
| EPS | 0.31 | ★ 2.43 |
| Revenue | $610,308,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $23.72 | $17.03 |
| Revenue Next Year | $6.89 | $3.82 |
| P/E Ratio | $89.16 | ★ $14.36 |
| Revenue Growth | ★ 7.53 | 4.12 |
| 52 Week Low | $25.73 | $28.25 |
| 52 Week High | $48.76 | $60.08 |
| Indicator | CDRE | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 32.40 | 42.21 |
| Support Level | $26.80 | $32.88 |
| Resistance Level | $30.34 | $37.92 |
| Average True Range (ATR) | 1.14 | 1.62 |
| MACD | -0.31 | -0.35 |
| Stochastic Oscillator | 8.29 | 0.00 |
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments - the Product segment, which is comprised of components that manufacture and sell products, and the Distribution segment, which is comprised of business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the Product segment, as well as other third-party products.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.